Department of Health
and Human Services (HHS)
and Human Services (HHS)
February 11, 2021
RFA-FD-21-013 - Physiologically-based pharmacokinetic (PBPK) models to aid the development of generic dermatological products (U01) Clinical Trials Optional
U.S. Food and Drug Administration (FDA)
This notice is to extend the Application Due Date for RFA-FD-21-013 - "Physiologically-based pharmacokinetic (PBPK) models to aid the development of generic dermatological products (U01) Clinical Trials Optional."
New Application Due Date(s)
February 18, 2021, by 11:59 PM Eastern Time
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the applications during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be acceptable for this FOA.
Shashi Malhotra
Grants Management Specialist
Office of Acquisitions and Grants Services
Tel: 240-402-7592
Email: Shashi.Malhotra@fda.hhs.gov